Expression of p16INK4a in relation to histopathology and viral load of 'high-risk' HPV types in cervical neoplastic lesions

European Journal of Cancer

Volumn 42, Issue 16, 2006, Pages 2815-2820

  Andersson, Sonia ^a   Wangsa, Darawalee ^a   Flores Staino, Carmen ^a   Safari, Hamzah ^a   Mints, Miriam ^a   Hjerpe, Anders ^a   Hagmar, Bjorn ^b   Johansson, Bo ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cervical neoplastic lesions; Human papillomavirus; p16INK4a; Viral load

Indexed keywords

PROTEIN P16INK4A;

ARTICLE; CANCER GRADING; CANCER RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; VIRUS LOAD; WART VIRUS;

ADULT; AGED; BIOPSY; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, NEOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; RISK FACTORS; UTERINE CERVICAL NEOPLASMS; VIRAL LOAD;

EID: 33750992174     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2006.06.023     Document Type: Article

References (31)

1. Bosch F.X., Lorinca A., Munoz N., Meijer C.J., and Shah K.V. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55 (2002) 244-265
2. Walboomers J.M., Jacobs M.V., Manos M.M., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 1 (1999) 12-19
3. Schiffman M.H., Bauer H.M., Hoover R.N., et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 85 12 (1993) 958-964
4. Winer R.L., Kiviat N., Hughes J.P., et al. Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis 191 5 (2005) 731-738
5. Nobbenhuis M.A., Walboomers J.M., Helmerhorst T.J., et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 354 9172 (1999) 20-25
6. Munoz N., Bosch F.X., de Sanjose S., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348 6 (2003) 518-527
7. Soutter W.P., and Fletcher A. Invasive cancer of the cervix in women with mild dyskaryosis followed up cytologically. BMJ 308 6941 (1994) 1421-1423
8. Josefsson A.M., Magnusson P.K., Ylitalo N., et al. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 355 9222 (2000) 2189-2192
9. Moberg M., Gustavsson I., Wilander E., and Gyllensten U. High viral loads of human papillomavirus predict risk of invasive cervical carcinoma. Br J Cancer 92 5 (2005) 891-894
10. Andersson S., Safari H., Mints M., Lewensohn-Fuchs I., Gyllensten U., and Johansson B. Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN). Br J Cancer 92 12 (2005) 2195-2200
11. Dray M., Russell P., Dalrymple C., et al. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies. Pathology 37 2 (2005) 112-124
12. Khleif S.N., DeGregori J., Yee C.L., et al. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proc Natl Acad Sci 93 9 (1995) 4350-4354
13. Masumoto N., Fujii T., Ishikawa M., et al. P16 overexpression and human papillomavirus infection in small cell carcinoma of the uterine cervix. Hum Pathol 34 8 (2003) 778-783
14. Sano T., Oyama T., Kashiwabara K., Fukuda T., and Nakajima T. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 153 (1998) 1741-1748
15. Klaes R., Friedrich T., Spitkovsky D., et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 92 2 (2001) 276-284
16. von Knebel Doeberitz M. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur J Cancer 38 17 (2002) 2229-2242
17. Murphy N., Heffron C.C., King B., et al. p16INK4A positivity in benign, premalignant and malignant cervical glandular lesions: a potential diagnostic problem. Virchows Arch 445 6 (2004) 610-615
18. Murphy N., Ring M., Heffron C.C., et al. p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer. J Clin Pathol 58 5 (2005) 525-534
19. Wang J.L., Zheng B.Y., Li X.D., Angstrom T., Lindstrom M.S., and Wallin K.L. Predictive significance of the alterations of p16INK4A, p14ARF, p53, and proliferating cell nuclear antigen expression in the progression of cervical cancer. Clin Cancer Res 10 7 (2004) 2407-2414
20. Klussmann J.P., Gultekin E., Weissenborn S.J., et al. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol 162 3 (2003) 747-753
21. Saqi A., Pasha T.L., McGrath C.M., Yu G.H., Zhang P., and Gupta P. Overexpression of p16INK4A in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia. Diagn Cytopathol 27 6 (2002) 365-370
22. Klaes R., Benner A., Friedrich T., et al. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 26 11 (2002) 1389-1399
23. Nielsen G.P., Stemmer-Rachamimov A.O., Shaw J., Roy J.E., Koh J., and Louis D.N. Immunohistochemical survey of p16INK4A expression in normal human adult and infant tissues. Lab Invest 79 9 (1999) 1137-1143
24. Sahebali S., Depuydt C.E., Segers K., Vereecken A.J., Van Marck E., and Bogers J.J. Ki-67 immunocytochemistry in liquid based cervical cytology: useful as an adjunctive tool?. J Clin Pathol 56 9 (2003) 681-686
25. Kruse A.J., Baak J.P., Janssen E.A., et al. Low- and high-risk CIN 1 and 2 lesions: prospective predictive value of grade, HPV, and Ki-67 immuno-quantitative variables. J Pathol 199 4 (2003) 462-470
26. Lorenzato M., Caudroy S., Bronner C., et al. Cell cycle and/or proliferation markers: what is the best method to discriminate cervical high-grade lesions?. Hum Pathol 36 10 (2005) 1101-1107
27. Cameron R.I., Maxwell P., Jenkins D., and McCluggage W.G. Immunohistochemical staining with MIB1, bcl2 and p16 assists in the distinction of cervical glandular intraepithelial neoplasia from tubo-endometrial metaplasia, endometriosis and microglandular hyperplasia. Histopathology 41 4 (2002) 313-321
28. Benevolo M., Mottolese M., Marandino F., Vocaturo G., Sindico R., and Piperno G. Immunohistochemical expression of p16 (INK4a) is predictive of HR-HPV infection in cevical low-grade lesions. Mod Pathol 19 3 (2006) 384-391
29. Bosch F.X., Manos M.M., Munoz N., et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 87 11 (1995) 796-802
30. Schiffman M.H., and Castle P. Epidemiologic studies of a necessary causal risk factor: human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst 95 6 (2003) E2
31. Andersson S., Dillner L., Elfgren K., Mints M., Persson M., and Rylander E. A comparison of the HPV test and Pap smear as a second screening method for women with minor cytological abnormalities. Acta Obstet Gynecol Scand 84 10 (2004) 996-1000